Skip to content

Evaluation of the fractional uptake rate (FUR) in 18F-FDG PET/CT to assess tumour metabolic activity

Evaluation of the fractional uptake rate (FUR) in 18F-FDG PET/CT to assess tumour metabolic activity - FUR evaluation in oncologic PET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53508
Enrollment
30
Registered
2022-08-11
Start date
2024-01-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, lymphoma Lung cancer, lymphoma

Interventions

N.A.

Sponsors

Maastricht Universitair Medisch Centrum +
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Oncologic patients who receive an 18F-FDG PET/CT scan for their standard care. Be competent and be 18 years or older

Exclusion criteria

Exclusion criteria: Diabetes Not fasted > 4 hours Physical exercise within 24 hours Active inflammation (fever > 38 degrees, CRP > 5) Any condition or medical indication (such as claustrophobia) that indicates  that the patient will not be able to lie still for the duration of the dynamic  PET/CT examination. Pregnant or breast feeding

Design outcomes

Primary

MeasureTime frame
Level of correlation between the FUR and Km and assess whether this is superior compared to the correlation between the SUV and Km.

Secondary

MeasureTime frame
Accuracy of the FUR to assess the glucose consumption of tumors. Inter-subject variation in time-integrated arterial 18F-FDG concentration.

Countries

Netherlands

Contacts

Public ContactR Wierts

Maastricht Universitair Medisch Centrum +

roel.wierts@mumc.nl0629633695

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026